Alcohol consumption and heart failure in hypertensive US male physicians

Luc Djoussé1, J Michael Gaziano

  • 1Division of Aging, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. ldjousse@rics.bwh.harvard.edu

Insights

Light to moderate alcohol consumption may lower heart failure risk in hypertensive men. Even higher intake showed a significant reduction in heart failure incidence.

Area of Science:

  • Cardiology
  • Epidemiology
  • Public Health

Background:

  • Heavy alcohol consumption is linked to increased blood pressure and alcoholic cardiomyopathy.
  • The relationship between light to moderate alcohol intake and heart failure (HF) risk in hypertensive individuals is not well understood.

Purpose of the Study:

  • To investigate the association between light to moderate alcohol consumption and the risk of incident heart failure (HF) among hypertensive male physicians.

Main Methods:

  • A prospective study of 5,153 hypertensive male physicians, free of major cardiovascular or cancer events at baseline.
  • Alcohol consumption was self-reported and categorized into four groups: <1, 1-4, 5-7, and >=8 drinks/week.
  • Heart failure (HF) cases were identified through follow-up questionnaires and validated using Framingham criteria.

Main Results:

  • A total of 478 incident heart failure (HF) cases were recorded during the follow-up period.
  • Compared to non-drinkers (<1 drink/week), hazard ratios for HF decreased with increasing alcohol consumption: 0.72 (1-4 drinks/week), 0.72 (5-7 drinks/week), and 0.38 (>=8 drinks/week).
  • A significant trend (p < 0.001) indicated a lower risk of HF with higher levels of alcohol consumption, even after adjusting for multiple confounding factors.

Conclusions:

  • Light to moderate alcohol consumption appears to be associated with a reduced risk of heart failure (HF) in hypertensive men.
  • These findings suggest a potential protective effect of certain levels of alcohol intake on HF development in this specific population.
  • Further research may be warranted to confirm these associations and explore underlying mechanisms.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.